TruBridge Merger with IKS Health Closes; Stock Delisted, Debt Paid Off
TBRG sits 89% above its 52-week low of $13.88.
Summary
TruBridge's acquisition by IKS Health closed today at $26.25 per share in cash. The stock is delisted, debt is paid off, and the company is now a private subsidiary.
Key Events · M&A and Partnerships · TBRG
-
Merger Closes
IKS Health completed its acquisition of TruBridge on July 9, 2026, with each share converted into the right to receive $26.25 in cash.
-
Stock Delisted
TruBridge common stock ceased trading prior to market open on July 9, 2026, and will be delisted from NASDAQ; the company will terminate its SEC reporting obligations.
-
Debt Paid Off
All outstanding obligations under the Amended and Restated Credit Agreement were paid in full and the agreement terminated, releasing all guarantees and liens.
-
Acquisition Financing
Parent funded the acquisition with $635.0 million in senior secured credit facilities; TruBridge will accede as a guarantor within 30 days.
Analysis · TBRG · Technology
The all-cash acquisition of TruBridge by IKS Health for $26.25 per share closed today, July 9, 2026. This finalizes the transaction announced in April, with TruBridge becoming a wholly owned subsidiary. The merger was funded by $635 million in debt financing arranged by IKS Health. TruBridge's common stock ceased trading and will be delisted from NASDAQ. All outstanding debt under the prior credit agreement was paid off and the agreement terminated. The board and certain officers were replaced, and the company's charter and bylaws were amended. For shareholders, this marks the end of TruBridge as a public company and the receipt of $26.25 per share in cash.
At the time of this filing, TBRG was trading at $26.24 on NASDAQ in the Technology sector, with a market capitalization of approximately $393.6M. The 52-week trading range was $13.88 to $26.51. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.